RQ-00015986

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameRQ-00015986

Drug Alias NameEP4 antagonist (RaQualia)prostaglandin E2 receptor 4 antagonist (RaQualia)RQ-00015986

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstanoid EP4 receptor antagonists

TargetsProstanoid EP4 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRaqualia Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A